Exporter Supply Landscape

Supplier countries for containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale

A reported trade view for HS 300339, with available observations through 2024.

HS6 300339Coverage 1995-2024Updated 2026-08-14
Explore this product

Leading supplier

Ireland$3.4B

Supplier countries

189Reported suppliers

Top supplier reach

24Destination markets

Latest global trade

$4.5BYear: 2024

Reported observations

Supplier evidence

Supplier countries ranked by latest reported export value.

SupplierLatest exports5-year growthDestinationsLeading destination
Ireland$3.4B+232.2%24Belgium
USA$356.9M+17%71Germany
Denmark$184.7M+22.5%27Poland
Poland$82.4M+3.3%12Denmark
China$43.7M+33.3%33Denmark
Kuwait$43.0M+38.9%8United Arab Emirates
Netherlands$42.9M+1.9%157Denmark
Belgium$41.8M+24.7%30USA
Germany$37.1M+4%43Denmark
Spain$30.0M+11.1%30Denmark
Hungary$24.1M-9.7%9Bulgaria
Pakistan$21.0M+20.8%32Afghanistan
India$19.6M-5.2%90USA
Canada$18.8M-14.1%19Ireland
South Africa$18.2M+7.2%19Namibia
France$18.2M+5.6%45Denmark
Portugal$17.1M+1.3%16Canada
Sweden$16.9M+7.9%14Austria
Austria$16.6M+3.4%15Italy
Switzerland, Liechtenstein$14.9M-24.2%22Italy
Italy$13.3M-1.4%50Denmark
Bulgaria$11.0M+26.7%11Denmark
United Kingdom$9.6M-20.6%40Switzerland, Liechtenstein
Greece$8.8M+14.7%14Denmark
Saudi Arabia$8.6M-52.5%3Jordan
Romania$7.7M+21.9%13Denmark
Turkey$7.7M-8.2%10Lebanon
Indonesia$6.7M-20%6Nigeria
Czechia$6.1M+9.8%17Denmark
Syrian Arab Republic$5.3M-39.9%1Yemen
Australia$4.9M-28.7%13Hungary
Ghana$4.8M-87.7%2United Rep. of Tanzania
Slovakia$4.8M+55.6%12Denmark
Lithuania$4.5M+26.9%8Denmark
United Arab Emirates$4.4M+17.4%23Iran

Market reading

Which countries supply containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale?

Ireland is the leading reported supplier in this view, with exports of $3.4B.

How to use this view

Start with the leading rows in the first table, then use the chart to compare supplier scale and destination reach for containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale. The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Supplier corridor unit-value evidence

Reported corridor unit values for the selected supplier, compared with each buyer market's median.

Buyer marketReported yearTrade valueQuantityUnit value USD/tonBuyer-market median USD/ton
Canada2023$6.0M1.9 t$3,107,659.79$103,837.21
Germany2023$953.7K1.9 t$515,216.1$515,216.1
Denmark2023$831.6K4.4 t$187,670.95$181,911.31
Czechia2023$702.9K0 t$29,288,791.67$341,500
Italy2023$316.0K0.1 t$2,306,321.17$107,390.22
Namibia2023$212.8K1.3 t$161,921.61$121,750
United Kingdom2023$145.4K14.2 t$10,218.44$116,454.55
Bulgaria2023$141.4K1.4 t$99,924.38$99,924.38
Netherlands2023$124.6K2.9 t$43,644.83$38,447.58
Spain2023$74.3K0.4 t$201,994.57$22,750
Estonia2023$58.9K0.1 t$449,748.09$383,085.71
Latvia2023$56.7K4.3 t$13,110.13$180,255
France2023$53.7K0.7 t$78,604.69$137,427
Hungary2023$51.7K0.1 t$397,653.85$887,500
Finland2023$40.7K0 t$1,566,769.23$1,566,769.23
Cyprus2023$12.9K0 t$559,434.78$119,375
Portugal2023$3.6K0 t$363,300$63,993.72
United Arab Emirates2023$545.00.3 t$1,953.41$17,500
USA2023$2.00 t$2,000$134,740
Denmark2022$1.2M4.6 t$271,051.24$142,189.4

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.